New Jersey Urology’s Center for Advanced Therapeutics offers advanced treatment options for patients faced with advanced prostate cancer.
PROVENGE is an immunotherapy and the only personalized treatment that is clinically proven to help extend life in certain men with advanced prostate cancer. Provenge immunotherapy takes your own immune cells and reprograms them to attack your advanced prostate cancer. This process delivers a treatment designed just for you.
Xofigo is used to treat prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has spread to your bones with symptoms, but not to other parts of your body. The medical term for this condition is metastatic castration-resistant prostate cancer, or mCRPC.